The Effect of the Use of Sterile Transparent Film Dressing in Newborns
The Effect of the Use of Sterile Transparent Film Dressing on the Duration of Catheter Stay and the Development of Catheter-Related Complications in Newborns
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey
- Yuksek Ihtisas University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- less than 4 kg (due to the infiltration scale criteria)
- PICV was inserted for the first time
Exclusion Criteria:
- existing catheter,
- who has a catheter other than PICV (PICC, umbilical catheter, etc.),
- sterile transparent film dressing, tape, babies with allergies to antiseptic solution and catheter,
- with immunodeficiency, and with skin problems that prevent catheter opening
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Experimental group: The group applied sterile transparent film dressing
The nurses in the unit were trained by the charge nurse of the clinic on catheter-related complications (infiltration, extravasation, phlebitis, and occlusion), the scales used in the study, and the use of sterile transparent film dressing.
In the experimental group, a sterile transparent film dressing was used to fix the catheter and was monitored hourly until the catheter was removed.
|
The nurses in the unit were trained by the charge nurse of the clinic on catheter-related complications (infiltration, extravasation, phlebitis, and occlusion), the scales used in the study, and the use of sterile transparent film dressing.
In the experimental group, a sterile transparent film dressing was used to fix the catheter and was monitored hourly until the catheter was removed.
The infiltration scale for infants, , the criteria of extravasation (Redness accompanied by a vesicle, tissue necrosis, and ulcer), and The Phlebitis Scale were used to evaluate the catheter site.
|
|
No Intervention: Control group: The group applied fixed with a tape (blaster)
The nurses in the unit were trained by the charge nurse of the clinic on catheter-related complications (infiltration, extravasation, phlebitis, and occlusion), the scales used in the study, and the use of sterile transparent film dressing.
In the control group, the catheter was fixed with a tape (blaster), routinely used in the clinic, and was monitored hourly until the catheter was removed.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The infiltration scale for infants
Time Frame: during catheter removal procedure
|
The scale published by the Infusion Nurses Association was revised by Tofani et al.
The adaptation of the scale to the newborns was carried out by Calikusu Incekar et al.
The scale consists of 5 grades: 0, 1, 2, 3, 4 and is applied to babies under 4 kg.
In this study, the infiltration scale was used to determine infiltration and extravasation.
In addition to the scale items, the criteria of "Redness accompanied by a vesicle, tissue necrosis, and ulcer" were also considered based on the literature to determine extravasation.
|
during catheter removal procedure
|
|
The Phlebitis Scale
Time Frame: during catheter removal procedure
|
The phlebitis scale published by the Infusion Nurses Society was used.
The scale consists of 5 grades: 0, 1, 2, 3, 4.
|
during catheter removal procedure
|
|
Occlusion
Time Frame: during catheter removal procedure
|
The nurse checked the infant's catheter site for occlusion.
|
during catheter removal procedure
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Suzan YILDIZ, PhD, Istanbul University - Cerrahpasa (IUC)
- Principal Investigator: Yağmur GÜL, BSN, Istanbul Florence Nightingale Hospital
- Principal Investigator: Ozan UZUNHAN, MD, Istanbul Florence Nightingale Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- YIU-M-CI-004
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.